GlassScriptPhysician profile
Katherine L Boyd
NPI 1922051358
$5,861.19
in general payments reported to CMS, 2019-2025
28 companies · $595 in 2025
The $595 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $3,344 · 2021: $699 · 2022: $448 · 2023: $318 · 2024: $274 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,073.57 | 2020-2021 | |
| Hologic Sales and Service, LLC | $452.02 | 2022-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Thinprep 2000 Processor |
| Coopersurgical, INC. | $369.41 | 2021-2025 | Summit Doppler, Endosee, Paragard T 380a |
| Abbvie INC. | $285.21 | 2019-2022 | |
| Sage Therapeutics, LLC | $228.19 | 2020-2025 | Zurzuvae |
| Pfizer INC. | $174.72 | 2019-2025 | |
| Lupin INC. | $164.36 | 2019-2020 | |
| Conmed Corporation | $117.04 | 2025 | Airseal |
| Medical Device Business Services, INC. | $107.10 | 2024 | Stratafix |
| Daiichi Sankyo INC. | $95.53 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $86.56 | 2022 | |
| Ascend Therapeutics US, LLC | $80.26 | 2021 | |
| Therapeuticsmd, INC. | $78.46 | 2019-2022 | |
| Evofem Biosciences, INC. | $77.33 | 2020-2021 | |
| Myovant Sciences INC. | $69.58 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $64.98 | 2021-2025 | Nexplanon |
| Convatec INC. | $55.23 | 2022-2023 | |
| Amgen INC. | $44.10 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $43.70 | 2023 | Rexulti |
| Scynexis, INC. | $32.48 | 2022 | |
| Merck Sharp & Dohme LLC | $23.76 | 2020 | |
| Exact Sciences Corporation | $22.93 | 2025 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $22.14 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.00 | 2020 | |
| Abbott Laboratories | $19.33 | 2024 | Proclaim |
| Meditrina | $17.59 | 2024 | |
| Avion Pharmaceuticals | $17.55 | 2021 | |
| Aspira Women'S Health INC | $16.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.